CLINICAL INFORMATION AND PHARMACOLOGY
Composition:
Each 2-ml ampoule and each coated 350-mg tablet contains:
Acetyl-coenzyme A dehydrogenase,
Acetyl-coenzyme A,
Oxidoreductase,
Lipase
Triacetyl glycerol,
Acetyl hydrolase,
Amino acid oxidase (contains flavin),
Amino acid oxygen oxidoreductase (deaminating) (contains flavin),
K3PO4 6 mg MnC12, 1 mg,
NaCI, 6 mg; CoC12, 1 mg,
MgSO4, 6 mg,
Diallyl sulphide, 2mg,
Triethanolamine salicylate, 2 mg
*Enzyme Nomenclature, 1992 IUBMB The International Union of Biochemistry and Molecular Biology
More Information |
||
| » Biolastin 2G » Clinical Information and Pharmacology » Mechanisms of Action » Pharmacokinetics |
» Cardiology » Biolastin 2G » Clinical Study » Bibliography |
» Exclusively For Doctors |